These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 30114562)

  • 1. The effect of surface poly(ethylene glycol) length on in vivo drug delivery behaviors of polymeric nanoparticles.
    Wang JL; Du XJ; Yang JX; Shen S; Li HJ; Luo YL; Iqbal S; Xu CF; Ye XD; Cao J; Wang J
    Biomaterials; 2018 Nov; 182():104-113. PubMed ID: 30114562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulating the surface poly(ethylene glycol) density of polymeric nanoparticles and evaluating its role in drug delivery in vivo.
    Du XJ; Wang JL; Liu WW; Yang JX; Sun CY; Sun R; Li HJ; Shen S; Luo YL; Ye XD; Zhu YH; Yang XZ; Wang J
    Biomaterials; 2015 Nov; 69():1-11. PubMed ID: 26275857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery.
    He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X
    Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oridonin-loaded poly(epsilon-caprolactone)-poly(ethylene oxide)-poly(epsilon-caprolactone) copolymer nanoparticles: preparation, characterization, and antitumor activity on mice with transplanted hepatoma.
    Feng N; Wu P; Li Q; Mei Y; Shi S; Yu J; Xu J; Liu Y; Wang Y
    J Drug Target; 2008 Jul; 16(6):479-85. PubMed ID: 18604660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly(epsilon-caprolactone)/poly(ethylene glycol)/poly(epsilon-caprolactone) nanoparticles: preparation, characterization, and application in doxorubicin delivery.
    Gou M; Zheng X; Men K; Zhang J; Zheng L; Wang X; Luo F; Zhao Y; Zhao X; Wei Y; Qian Z
    J Phys Chem B; 2009 Oct; 113(39):12928-33. PubMed ID: 19736995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive study of the drug delivery properties of poly(l-lactide)-poly(ethylene glycol) nanoparticles in rats and tumor-bearing mice.
    Shalgunov V; Zaytseva-Zotova D; Zintchenko A; Levada T; Shilov Y; Andreyev D; Dzhumashev D; Metelkin E; Urusova A; Demin O; McDonnell K; Troiano G; Zale S; Safarovа E
    J Control Release; 2017 Sep; 261():31-42. PubMed ID: 28611009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shedding light on surface exposition of poly(ethylene glycol) and folate targeting units on nanoparticles of poly(ε-caprolactone) diblock copolymers: Beyond a paradigm.
    Venuta A; Moret F; Dal Poggetto G; Esposito D; Fraix A; Avitabile C; Ungaro F; Malinconico M; Sortino S; Romanelli A; Laurienzo P; Reddi E; Quaglia F
    Eur J Pharm Sci; 2018 Jan; 111():177-185. PubMed ID: 28966100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
    Rafiei P; Haddadi A
    Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor efficiency of D-alpha-tocopheryl polyethylene glycol 1000 succinate-b-poly(epsilon-caprolactone-ran-lactide) nanoparticle-based delivery of docetaxel in mice bearing cervical cancer.
    Wang Z; Zeng X; Ma Y; Liu J; Tang X; Gao Y; Liu K; Zhang J; Ming P; Huang L; Mei L
    J Biomed Nanotechnol; 2014 Aug; 10(8):1509-19. PubMed ID: 25016651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of polyaspartic acid peptide-poly (ethylene glycol)-poly (ε-caprolactone) nanoparticles as a carrier of hydrophobic drugs targeting cancer metastasized to bone.
    Liu J; Zeng Y; Shi S; Xu L; Zhang H; Pathak JL; Pan Y
    Int J Nanomedicine; 2017; 12():3561-3575. PubMed ID: 28507436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gambogic acid-loaded PEG-PCL nanoparticles act as an effective antitumor agent against gastric cancer.
    Zhang D; Zou Z; Ren W; Qian H; Cheng Q; Ji L; Liu B; Liu Q
    Pharm Dev Technol; 2018 Jan; 23(1):33-40. PubMed ID: 29069711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of PEG conformation and particle size on the cellular uptake efficiency of nanoparticles with the HepG2 cells.
    Hu Y; Xie J; Tong YW; Wang CH
    J Control Release; 2007 Mar; 118(1):7-17. PubMed ID: 17241684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) (PCL-PEG-PCL) nanoparticles for honokiol delivery in vitro.
    Gou M; Zheng L; Peng X; Men K; Zheng X; Zeng S; Guo G; Luo F; Zhao X; Chen L; Wei Y; Qian Z
    Int J Pharm; 2009 Jun; 375(1-2):170-6. PubMed ID: 19427143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Degradation and cell culture studies on block copolymers prepared by ring opening polymerization of epsilon-caprolactone in the presence of poly(ethylene glycol).
    Huang MH; Li S; Hutmacher DW; Schantz JT; Vacanti CA; Braud C; Vert M
    J Biomed Mater Res A; 2004 Jun; 69(3):417-27. PubMed ID: 15127388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stabilization of poly(ethylene glycol)-poly(ε-caprolactone) star block copolymer micelles via aromatic groups for improved drug delivery properties.
    Buwalda S; Al Samad A; El Jundi A; Bethry A; Bakkour Y; Coudane J; Nottelet B
    J Colloid Interface Sci; 2018 Mar; 514():468-478. PubMed ID: 29289031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of poly(ethylene glycol)-b-poly(epsilon-caprolactone) copolymers with different Poly(ethylene glycol) contents for the preparation of PEG-coated nanoparticles.
    Hou J; Qian C; Zhang Y; Guo S
    J Biomed Nanotechnol; 2013 Feb; 9(2):231-7. PubMed ID: 23627049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fine tuning micellar core-forming block of poly(ethylene glycol)-block-poly(ε-caprolactone) amphiphilic copolymers based on chemical modification for the solubilization and delivery of doxorubicin.
    Yan J; Ye Z; Chen M; Liu Z; Xiao Y; Zhang Y; Zhou Y; Tan W; Lang M
    Biomacromolecules; 2011 Jul; 12(7):2562-72. PubMed ID: 21598958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticles from Gantrez® AN-poly(ethylene glycol) conjugates as carriers for oral delivery of docetaxel.
    Ruiz-Gatón L; Espuelas S; Huarte J; Larrañeta E; Martin-Arbella N; Irache JM
    Int J Pharm; 2019 Nov; 571():118699. PubMed ID: 31536764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influencing Selectivity to Cancer Cells with Mixed Nanoparticles Prepared from Albumin-Polymer Conjugates and Block Copolymers.
    Jiang Y; Wong S; Chen F; Chang T; Lu H; Stenzel MH
    Bioconjug Chem; 2017 Apr; 28(4):979-985. PubMed ID: 28263565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of a paclitaxel-binding polymeric micelle for efficient breast cancer therapy.
    Xiang J; Wu B; Zhou Z; Hu S; Piao Y; Zhou Q; Wang G; Tang J; Liu X; Shen Y
    Sci China Life Sci; 2018 Apr; 61(4):436-447. PubMed ID: 29572777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.